[Federal Register Volume 88, Number 185 (Tuesday, September 26, 2023)]
[Notices]
[Pages 66003-66004]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-20759]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-23-1305]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``Chronic Q Fever in the United States: 
Enhanced Clinical Surveillance'' to the Office of Management and Budget 
(OMB) for review and approval. CDC previously published a ``Proposed 
Data Collection Submitted for Public Comment and Recommendations'' 
notice on June 27, 2023 to obtain comments from the public and affected 
agencies. CDC received no comments related to the previous notice. This 
notice serves to allow an additional 30 days for public and affected 
agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    Chronic Q Fever in the United States: Enhanced Clinical 
Surveillance (OMB Control No. 0920-1305, Exp. 9/30/2023)--Revision--
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), 
Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Q fever is a worldwide zoonosis caused by Coxiella burnetii with 
acute and chronic disease presentations. Chronic Q fever can manifest 
months to years after the primary infection and is rare, occurring in 
<5% of persons with an acute infection. Chronic Q fever can take on 
several clinical forms, including endocarditis, chronic hepatitis, 
chronic vascular infections, osteomyelitis, and osteoarthritis. In the 
United States, Q fever cases are reported via the National Notifiable 
Disease Surveillance System; however, limited information is collected 
on the various clinical manifestations of chronic Q fever or patients 
pre-existing risk factors. Data on outcomes other than death or 
hospitalizations are not collected by the current surveillance. Because 
of this lack of data, the true burden and proportion of cases 
exhibiting endocarditis and other forms of chronic Q fever in the 
United States is unknown. We plan to establish an enhanced medical 
surveillance for chronic Q fever by working with consulting clinicians 
to gather additional and more specific clinical data not otherwise 
collected during the course of routine public health surveillance for 
chronic Q fever. This information will allow for better 
characterization of the clinical presentation and risk factors of 
chronic Q fever in the United States. The results will help 
characterize an under-recognized disease and provide valuable data to 
educate physicians on identifying and diagnosing these cases.
    Recently, there has been an increased volume of clinical 
consultation requests. To reflect this, we are proposing an increase in 
the number of respondents to 50 each year. Additionally, the clinical 
course for these patients is often complex, and clinical relapse or 
prolonged infection has been reported. To capture these important 
clinical details, we propose increasing the number of total instruments 
to two, with a follow-up survey that will take five minutes each at 
six, 12, 18, and 24 months from the date of the initial consult.
    CDC requests OMB approval for an estimated 34 annual burden hours. 
There is no cost to respondents other than their time to participate.

[[Page 66004]]



                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondents                   Form name            Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
Physician.............................  Chronic Q fever Enhanced              50               1           20/60
                                         Surveillance Report
                                         Form--Initial Consult.
Physician.............................  Chronic Q fever Enhanced              50               2           10/60
                                         Surveillance Report
                                         Form--Follow-up.
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2023-20759 Filed 9-25-23; 8:45 am]
BILLING CODE 4163-18-P